DEA schedules Epidiolex, allowing GW Pharma to start selling the drug

The Drug Enforcement Administration has rescheduled Epidiolex, paving the way GW Pharmaceuticals to start selling the first FDA-approved drug that’s derived from cannabis, but stopping short of resclassifying all cannabidiol products.

Source

The post DEA schedules Epidiolex, allowing GW Pharma to start selling the drug appeared first on Cannabis Stock Picks.

Go to OG News Source
Author: Admin
{authorlink}